Centocor in Europe
Detail force is being established to sell Centocor cardiovascular diagnostic imaging products in Europe. Based in Leiden, The Netherlands, the sales effort initially will be directed at selected common market countries such as BeneLux and Germany, Centocor said. The sales force will be assembled and directed by Michael Bouillet, who joined Centocor in 1988 as VP-image product marketing and sales. Bouillet previously was president of U.S. radiopharmaceutical distributor Syncor. Initial focus in Europe will be the launch of Myoscint and Fibriscint.
You may also be interested in...
Centus Biotherapeutics has received formal European Commission approval for its Equidacent biosimilar rival to Avastin.
The IGBA has called for a “streamlined” global biosimilar development and registration process, with a new policy paper highlighting the limited value of comparative efficacy clinical data at the same time as it urges renewed efforts on educating healthcare professionals.
Data from the first 275 patients in the trial are promising, but outside experts say they are wary of another hasty Emergency Use Authorization.